GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Insider Ownership

Voluntis (XPAR:ALVTX) Insider Ownership : 0.00 % (As of Jun. 19, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Voluntis's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Voluntis's Institutional Ownership is 4.56%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Voluntis's Float Percentage Of Total Shares Outstanding is 0.00%.


Voluntis Insider Ownership Historical Data

The historical data trend for Voluntis's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Insider Ownership Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Insider Ownership
- - - - -

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voluntis Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines